Cat. #161692
Anti-CD16 monoclonal antibody [GRM1]
Cat. #: 161692
Sub-type: Primary antibody
Availability: 3-4 weeks
Target: CD16
Class: Monoclonal
Application: FACS; IHC; ELISA; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot and Federico Garrido Torres-Puchol
Institute: Virgen de las Nieves University Hospital, The Andalusian Health Service
Primary Citation: Ruiz-Cabello et al. 1987. Nat Immun Cell Growth Regul. 6(2):99-108. PMID: 2439907
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CD16 monoclonal antibody [GRM1]
- Cancer: Blood cancer
- Research fields: Cancer
- Clone: GRM1
- Tool sub type: Primary antibody
- Class: Monoclonal
- Molecular weight: 50-65 kDa
- Reactivity: Human
- Host: Mouse
- Application: FACS; IHC; ELISA; WB
- Description: CD16 antigen constitutes the low affinity FC receptor for IgG(FcgRIII) DE 50-65 kDA. It is a membrane glycoprotein anchored via phosphatidyl-inositol or a transmembrane isoform. CD16 is expressed by NK cells, granulocytes and macrophages.
- Immunogen: B-ALL cells
- Isotype: IgG1ak
- Recommended controls: Granulocytes neutrophils, NK cells
Target Details
- Target: CD16
- Molecular weight: 50-65 kDa
Applications
- Application: FACS; IHC; ELISA; WB
Handling
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Ruiz-Cabello et al. 1987. Nat Immun Cell Growth Regul. 6(2):99-108. PMID: 2439907
